An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients in ...
Patients with moderate to severe acute respiratory distress syndrome receiving a monoclonal antibody treatment vs. placebo ...
Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A frequent cause of death during the COVID-19 pandemic, ARDS ...
Cumulative survival (A) on admission (<30 vs. ≥30), ICU admission reason (B, admitted for acute respiratory failure vs. admitted for other reasons), and PaO2/FiO2 ratio (C, ≤100 mmHg vs. >100 mmHg) at ...
In a recent study published in the journal Circulation, researchers investigate the inflammatory response to acute respiratory distress syndrome (ARDS) within the heart. Study: Virus-Induced Acute ...
A new Northwestern Medicine study has discovered a novel therapeutic target and therapeutic agents for older patients with acute respiratory distress syndrome (ARDS), according to recent findings ...
In a new report posted online in the American Journal of Respiratory and Critical Care Medicine, a global consensus conference of 32 critical care experts with broad international representation and ...
Could relying on familiar fluid responsiveness tests be misleading in ARDS care? For critical care physicians, fluid ...
Researchers at Endeavor Health and Northwestern University have created an artificial intelligence-based tool to help doctors recognize an underdiagnosed, often fatal respiratory syndrome found in ...
Researchers may have discovered a mechanical explanation for instability observed in the lungs in cases of acute respiratory distress syndrome (ARDS), particularly in the aftermath of respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results